Area of research
Pathology and Forensic Medicine · Immunology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, T-cell and B-cell Immunology, and Immune Cell Function and Interaction.
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
Single-Cell Transcriptomics Identifies a Prominent Role for the MIF-CD74 Axis in Myasthenia Gravis Thymus
Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events
Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy–A pilot study
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases
International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis
Functional Signature of LRP4 Antibodies in Myasthenia Gravis
Ravulizumab and Efgartigimod in Myasthenia Gravis
Fatigue and associated factors in myasthenia gravis: a nationwide registry study
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes
Complement activation profiles in <scp>anti‐acetylcholine receptor</scp> positive myasthenia gravis
Association of obesity with disease outcome in multiple sclerosis
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis
Complement Activation Is a Prominent Feature of <scp>MOGAD</scp>
Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
The initiation and prevention of multiple sclerosis